BioMarin (BMRN) announced positive new data from studies of Voxzogo in children with achondroplasia and in ongoing clinical trials ...

Achondroplasia is a type of dwarfism that affects the growth in children, leading to a short stature or small size. Achondroplasia is a rare genetic condition that affects one in every 15,000 to ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc.

Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. Between the ...

(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) announced positive new data from studies of VOXZOGO in children with achondroplasia and in ongoing clinical trials investigating other skeletal ...

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. However, these line-in-the-sand corrections were relatively short-lived. The S&P ...

Between Feb. 19 and Mar. 13, the growth-fueled Nasdaq Composite lost 13.7% of its value and entered correction territory. Although the Nasdaq moved out of correction on Mar. 24, bargains still abound.

BioMarin’s Voxzogo has been shown to increase growth rates in children with hypochondroplasia, a genetic cause of very short stature, in a phase 2 trial. Hypochondroplasia is a form of skeletal ...